Caplin Point Laboratories cash flow

Latest FY26

Cash from operations: ₹523cr+21.0% on FY25
Capital spending: ₹248cr+29.6% on FY25
Free cash flow: ₹275cr+14.2% on FY25
Cash from financing: −₹46.5cr−₹38.3 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	72.8	66.0	53.4	45.0
	—	0.9	0.6	0.8	0.8
	—	−77.6	−63.6	−47.3	−35.4
	—	−2.1	−5.0	−0.9	0.5
	—	0.0	0.0	0.9	5.2
	—	0.0	−3.5	−0.9	−1.2
	—	117	34.3	11.5	42.4
	—	4.2	3.8	0.0	0.0
	—	−92.8	26.9	−74.8	−60.9
	—	−179	−87.8	−149	−74.0
	—	−3.4	−2.3	−1.4	−0.2
	—	−44.5	−54.3	−2.6	−42.9
	—	69.0	−28.8	69.3	32.3
Cash from operating activities
	844	803	677	564	451
	—	−135	−114	−141	−88.4
	—	668	563	424	363
	—	0.0	0.0	−3.7	−3.2
	—	145	131	109	88.2
	—	523	432	311	272
Cash from investing activities
	—	248	192	146	194
	—	268	214	93.8	141
	—	62.4	51.7	43.7	26.8
	—	−128	18.8	−117	90.3
	—	−582	−335	−313	−218
Cash from financing activities
	—	0.0	0.0	0.0	0.0
	—	0.0	0.3	−3.1	2.9
	—	0.9	0.6	0.8	0.8
	—	45.6	38.0	34.2	30.3
	—	−46.5	−38.3	−38.1	−28.2
	—	−106	59.3	−39.7	25.6
	—	0.3	0.0	0.9	1.2
	—	−105	59.3	−38.9	26.8
	—	—	—	139	178
Reference items
	797	761	647	551	441
	34.8%	34.8%	33.4%	32.6%	30.1%
	275	275	241	165	77.9
	—	274	240	162	—
	₹36.20	₹36.20	₹31.69	₹21.73	₹10.25
	65.64×	—	—	—	—
	—	0.81×	0.80×	0.67×	0.72×
	—	145	131	109	88.2
	—	0.9	0.6	0.8	0.8

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CAPLIPOINT₹2,376.10

Caplin Point Laboratories Ltd.

· Pharma & Health

₹ CrorePeersAJANTPHARM ERIS GLAND BLUEJET CONCORDBIO ACUTAAS EMCURE GRANULESMcap ₹18,058 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	45.0	53.4	66.0	72.8	—
+ Finance Costs	0.8	0.8	0.6	0.9	—
+ Interest Income	-35.4	-47.3	-63.6	-77.6	—
+ Fair Value (Gains) / Losses	0.5	-0.9	-5.0	-2.1	—
+ Share-based Payments	5.2	0.9	0.0	0.0	—
+ Unrealised FX (Gain) / Loss	-1.2	-0.9	-3.5	0.0	—
+ Other Non-cash Items	42.4	11.5	34.3	117.4	—
+ Other — Cash Effects are Investing / Financing	0.0	0.0	3.8	4.2	—
Changes in Working Capital
+ Inventories	-60.9	-74.8	26.9	-92.8	—
+ Trade Receivables — Current	-74.0	-148.7	-87.8	-178.7	—
+ Other Financial Assets — Current	-0.2	-1.4	-2.3	-3.4	—
+ Other Current Assets	-42.9	-2.6	-54.3	-44.5	—
+ Trade Payables — Current	32.3	69.3	-28.8	69.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	451.4	564.4	676.8	802.8	843.6
+ Total Adjustments (incl. Working Capital)	-88.4	-140.6	-113.8	-135.1	—
Cash from Operations (pre-tax)	363.0	423.8	563.0	667.7	—
+ Other Inflows / (Outflows) — Operating	-3.2	-3.7	0.0	0.0	—
+ Income Taxes Paid	88.2	109.2	130.6	144.5	—
Cash from Operating Activities	271.7	311.0	432.4	523.2	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	193.8	145.8	191.5	248.1	—
+ Purchase of Investments (Equity / Debt)	141.3	93.8	213.8	268.3	—
+ Interest Received — Investing	26.8	43.7	51.7	62.4	—
+ Other Inflows / (Outflows) — Investing	90.3	-116.8	18.8	-128.3	—
Cash from Investing Activities	-217.9	-312.6	-334.7	-582.3	—
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options	0.0	0.0	0.0	0.0	—
+ Proceeds from Borrowings	2.9	-3.1	0.3	0.0	—
+ Interest Paid	0.8	0.8	0.6	0.9	—
+ Dividends Paid	30.3	34.2	38.0	45.6	—
Cash from Financing Activities	-28.2	-38.1	-38.3	-46.5	—
Net Changes in Cash (pre-FX)	25.6	-39.7	59.3	-105.5	—
+ Effect of FX Rate Changes on Cash	1.2	0.9	0.0	0.3	—
Net Changes in Cash	26.8	-38.9	59.3	-105.3	—
Closing Cash	177.6	138.7	—	—	—
Reference Items
EBITDA	441.1	551.4	646.9	760.9	796.6
EBITDA Margin %	30.07	32.55	33.39	34.79	34.83
Free Cash Flow (CFO − Capex)	77.9	165.2	240.9	275.1	275.1
Free Cash Flow to Equity	—	162.2	239.6	274.3	—
Free Cash Flow per Basic Share	10.25	21.73	31.69	36.20	36.20
Price to Free Cash Flow	—	—	—	—	65.64
Cash Flow to Net Income	0.72	0.67	0.80	0.81	—
Cash Paid for Taxes	88.2	109.2	130.6	144.5	—
Cash Paid for Interest	0.8	0.8	0.6	0.9	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.